Oncodesign Precision Medicine Société anonyme (EPA:ALOPM)
France · Delayed Price · Currency is EUR 0.3290
-0.0010 (-0.30%)
Last updated: Jul 14, 2026, 9:00 AM CET
EPA:ALOPM Market Cap
EPA:ALOPM has a market cap or net worth of €6.28 million as of July 14, 2026. Its market cap has increased by 8.07% in one year.
Market Cap
6.28M
Enterprise Value
10.55M
Revenue
1.81M
Ranking
n/a
PE Ratio
1.10
Stock Price
€0.33
Market Cap Chart
Since October 5, 2022, EPA:ALOPM's market cap has increased from 5.82M to 6.28M, an increase of 7.89%. That is a compound annual growth rate of 2.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 6.28M | -15.84% |
| Dec 31, 2025 | 7.47M | -42.44% |
| Dec 31, 2024 | 12.97M | -56.74% |
| Dec 29, 2023 | 29.99M | 155.14% |
| Dec 30, 2022 | 11.75M | 101.80% |
| Oct 5, 2022 | 5.82M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Advicenne | 25.75M |
| genOway Société anonyme | 22.13M |
| GenSight Biologics | 19.27M |
| Aelis Farma | 14.28M |
| Poxel | 10.96M |
| NFL Biosciences | 10.77M |
| Aton | 8.78M |
| Plant Advanced Technologies | 7.19M |